Regulation of the CRL4Cdt2 ubiquitin ligase and Cell-Cycle exit by the SCFFbxo11 ubiquitin ligase

Molecular Cell

Volumn 49, Issue 6, 2013, Pages 1159-1166

  Rossi, Mario ^a,g   Duan, Shanshan ^a,b   Jeong, Yeon Tae ^a   Horn, Moritz ^c,d   Saraf, Anita ^e   Florens, Laurence ^e   Washburn, Michael P ^e,f   Antebi, Adam ^c,d   Pagano, Michele ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Howard Hughes Medical Institute   (Germany)

^c MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^f UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^g Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CDT2 PROTEIN; CELL CYCLE PROTEIN; F BOX PROTEIN; FBXO11 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; MASS SPECTROMETRY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PURIFICATION; REGULATORY MECHANISM;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL CYCLE; CELL DIFFERENTIATION; CONSERVED SEQUENCE; F-BOX PROTEINS; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HELA CELLS; HUMANS; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-ARGININE N-METHYLTRANSFERASES; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES;

EID: 84875804530     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.02.004     Document Type: Article

References (35)

1. Abbas T., Dutta A. CRL4Cdt2: master coordinator of cell cycle progression and genome stability. Cell Cycle 2011, 10:241-249.
2. Abbas T., Sivaprasad U., Terai K., Amador V., Pagano M., Dutta A. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 2008, 22:2496-2506.
3. Abbas T., Shibata E., Park J., Jha S., Karnani N., Dutta A. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol. Cell 2010, 40:9-21.
4. Bashir T., Dorrello N.V., Amador V., Guardavaccaro D., Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 2004, 428:190-193.
5. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. Cancer Genome Atlas Research Network.
6. Cardozo T., Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 2004, 5:739-751.
7. Centore R.C., Havens C.G., Manning A.L., Li J.M., Flynn R.L., Tse A., Jin J., Dyson N.J., Walter J.C., Zou L. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol. Cell 2010, 40:22-33.
8. D'Angiolella V., Donato V., Vijayakumar S., Saraf A., Florens L., Washburn M.P., Dynlacht B., Pagano M. SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation. Nature 2010, 466:138-142.
9. D'Angiolella V., Donato V., Forrester F.M., Jeong Y.T., Pellacani C., Kudo Y., Saraf A., Florens L., Washburn M.P., Pagano M. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell 2012, 149:1023-1034.
10. Duan S., Skaar J.R., Kuchay S., Toschi A., Kanarek N., Ben-Neriah Y., Pagano M. mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTOR. Mol. Cell 2011, 44:317-324.
11. Duan S., Cermak L., Pagan J.K., Rossi M., Martinengo C., di Celle P.F., Chapuy B., Shipp M., Chiarle R., Pagano M. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas. Nature 2012, 481:90-93.
12. Fielenbach N., Guardavaccaro D., Neubert K., Chan T., Li D., Feng Q., Hutter H., Pagano M., Antebi A. DRE-1: an evolutionarily conserved F box protein that regulates C. elegans developmental age. Dev. Cell 2007, 12:443-455.
13. Florens L., Washburn M.P. Proteomic analysis by multidimensional protein identification technology. Methods Mol. Biol. 2006, 328:159-175.
14. Frescas D., Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 2008, 8:438-449.
15. Hardisty-Hughes R.E., Tateossian H., Morse S.A., Romero M.R., Middleton A., Tymowska-Lalanne Z., Hunter A.J., Cheeseman M., Brown S.D. A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse. Hum. Mol. Genet. 2006, 15:3273-3279.
16. Havens C.G., Walter J.C. Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Genes Dev. 2011, 25:1568-1582.
17. Higa L.A., Banks D., Wu M., Kobayashi R., Sun H., Zhang H. L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage. Cell Cycle 2006, 5:1675-1680.
18. Jørgensen S., Eskildsen M., Fugger K., Hansen L., Larsen M.S., Kousholt A.N., Syljuåsen R.G., Trelle M.B., Jensen O.N., Helin K., Sørensen C.S. SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation. J. Cell Biol. 2011, 192:43-54.
19. Kamath R.S., Martinez-Campos M., Zipperlen P., Fraser A.G., Ahringer J. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2001, 2:H0002.
20. Kan Z., Jaiswal B.S., Stinson J., Janakiraman V., Bhatt D., Stern H.M., Yue P., Haverty P.M., Bourgon R., Zheng J., et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010, 466:869-873.
21. Kim Y., Starostina N.G., Kipreos E.T. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Genes Dev. 2008, 22:2507-2519.
22. Lee J.E., Sweredoski M.J., Graham R.L., Kolawa N.J., Smith G.T., Hess S., Deshaies R.J. The steady-state repertoire of human SCF ubiquitin ligase complexes does not require ongoing Nedd8 conjugation. Mol. Cell. Proteomics 2011, 10. M110.006460.
23. Lipkowitz S., Weissman A.M. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 2011, 11:629-643.
24. Lohr J.G., Stojanov P., Lawrence M.S., Auclair D., Chapuy B., Sougnez C., Cruz-Gordillo P., Knoechel B., Asmann Y.W., Slager S.L., et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc. Natl. Acad. Sci. USA 2012, 109:3879-3884.
25. Oda H., Hübner M.R., Beck D.B., Vermeulen M., Hurwitz J., Spector D.L., Reinberg D. Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage. Mol. Cell 2010, 40:364-376.
26. Petroski M.D., Deshaies R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2005, 6:9-20.
27. Segade F., Daly K.A., Allred D., Hicks P.J., Cox M., Brown M., Hardisty-Hughes R.E., Brown S.D., Rich S.S., Bowden D.W. Association of the FBXO11 gene with chronic otitis media with effusion and recurrent otitis media: the Minnesota COME/ROM Family Study. Arch. Otolaryngol. Head Neck Surg. 2006, 132:729-733.
28. Skaar J.R., D'Angiolella V., Pagan J.K., Pagano M. SnapShot: F box proteins II. Cell 2009, 137:1358. 1358, e1.
29. Skaar J.R., Pagan J.K., Pagano M. SnapShot: F box proteins I. Cell 2009, 137:1160. e1.
30. Slack F.J., Basson M., Liu Z., Ambros V., Horvitz H.R., Ruvkun G. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor. Mol. Cell 2000, 5:659-669.
31. Stransky N., Egloff A.M., Tward A.D., Kostic A.D., Cibulskis K., Sivachenko A., Kryukov G.V., Lawrence M.S., Sougnez C., McKenna A., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
32. Tateossian H., Hardisty-Hughes R.E., Morse S., Romero M.R., Hilton H., Dean C., Brown S.D. Regulation of TGF-beta signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant. Pathogenetics 2009, 2:5.
33. Wei W., Ayad N.G., Wan Y., Zhang G.J., Kirschner M.W., Kaelin W.G. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 2004, 428:194-198.
34. Yen H.C., Elledge S.J. Identification of SCF ubiquitin ligase substrates by global protein stability profiling. Science 2008, 322:923-929.
35. Yoshida K., Sanada M., Shiraishi Y., Nowak D., Nagata Y., Yamamoto R., Sato Y., Sato-Otsubo A., Kon A., Nagasaki M., et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011, 478:64-69.